AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33

Authors: Molinier-Frenkel, V Lengagne, R Gaden, F Hong, SS Choppin, J Gahery-Segard, H Boulanger, P Guillet, JG
Citation: V. Molinier-frenkel et al., Adenovirus hexon protein is a potent adjuvant for activation of a cellularimmune response, J VIROLOGY, 76(1), 2002, pp. 127-135

Authors: Quesnel, A Zerbib, A Connan, F Guillet, JG Briand, JP Choppin, J
Citation: A. Quesnel et al., Synthesis and antigenic properties of reduced peptide bond analogues of animmunodominant epitope of the melanoma MART-1 protein, J PEPT SCI, 7(3), 2001, pp. 157-165

Authors: Baratin, M Ziol, M Romieu, R Kayibanda, M Gouilleux, F Briand, P Leroy, P Haddada, H Renia, L Viguier, M Guillet, JG
Citation: M. Baratin et al., Regression of primary hepatocarcinoma in cancer-prone transgenic mice by local interferon-gamma delivery is associated with macrophages recruitment and nitric oxide production, CANC GENE T, 8(3), 2001, pp. 193-202

Authors: Andrieu, M Chassin, D Desoutter, JF Bouchaert, I Baillet, M Hanau, D Guillet, JG Hosmalin, A
Citation: M. Andrieu et al., Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8(+) T lymphocytes, AIDS RES H, 17(14), 2001, pp. 1365-1370

Authors: Pialoux, G Gahery-Segard, H Sermet, S Poncelet, H Fournier, S Gerard, L Tartar, A Gras-Masse, H Levy, JP Guillet, JG
Citation: G. Pialoux et al., Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers, AIDS, 15(10), 2001, pp. 1239-1249

Authors: Ferries, E Connan, F Pages, F Gaston, J Hagnere, AM Vieillefond, A Thiounn, N Guillet, JG Choppin, J
Citation: E. Ferries et al., Identification of p53 peptides recognized by CD8(+) T lymphocytes from patients with bladder cancer, HUMAN IMMUN, 62(8), 2001, pp. 791-798

Authors: Ziol, M Tepper, M Lohez, M Arcangeli, G Ganne, N Christidis, C Trinchet, JC Beaugrand, M Guillet, JG Guettier, C
Citation: M. Ziol et al., Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis, J HEPATOL, 34(2), 2001, pp. 254-260

Authors: Hosmalin, A Andrieu, M Loing, E Desoutter, JF Hanau, D Gras-Masse, H Dautry-Varsat, A Guillet, JG
Citation: A. Hosmalin et al., Lipopeptide presentation pathway in dendritic cells, IMMUNOL LET, 79(1-2), 2001, pp. 97-100

Authors: Couillin, I Letourneur, F Lefebvre, P Guillet, JG Martinon, F
Citation: I. Couillin et al., DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses, VIROLOGY, 279(1), 2001, pp. 136-145

Authors: Marchal-Bras-Goncalves, R Rouas-Freiss, N Connan, F Choppin, J Dausset, J Carosella, ED Kirszenbaum, M Guillet, JG
Citation: R. Marchal-bras-goncalves et al., A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity, TRANSPLAN P, 33(3), 2001, pp. 2355-2359

Authors: Choppin, J Cohen, W Bianco, A Briand, JP Connan, F Dalod, M Guillet, JG
Citation: J. Choppin et al., Characteristics of HIV-1 Nef regions containing multiple CD8(+) T cell epitopes: Wealth of HLA-binding motifs and sensitivity to proteasome degradation, J IMMUNOL, 166(10), 2001, pp. 6164-6169

Authors: Molinier-Frenkel, V Le Boulaire, C Le Gal, FA Gahery-Segard, H Tursz, T Guillet, JG Farace, F
Citation: V. Molinier-frenkel et al., Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patients, HUM GENE TH, 11(13), 2000, pp. 1911-1920

Authors: Guillet, JG
Citation: Jg. Guillet, Viral escaping mechanisms, M S-MED SCI, 16(8-9), 2000, pp. 874-882

Authors: Mortara, L Letourneur, F Villefroy, P Beyer, C Gras-Masse, H Guillet, JG Bourgault-Villada, I
Citation: L. Mortara et al., Temporal loss of Nef-epitope CTL recognition following macaque lipopeptideimmunization and SIV challenge, VIROLOGY, 278(2), 2000, pp. 551-561

Authors: Gahery-Segard, H Pialoux, G Charmeteau, B Sermet, S Poncelet, H Raux, M Tartar, A Levy, JP Gras-Masse, H Guillet, JG
Citation: H. Gahery-segard et al., Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine, J VIROLOGY, 74(4), 2000, pp. 1694-1703

Authors: Molinier-Frenkel, V Gawery-Segard, H Mentali, M Le Boulaire, C Ribault, S Boulanger, P Tursz, T Guillet, JG Farace, F
Citation: V. Molinier-frenkel et al., Immune response to recombinant adenovirus in humans: Capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes, J VIROLOGY, 74(16), 2000, pp. 7678-7682

Authors: Guichard, G Zerbib, A Le Gal, FA Hoebeke, J Connan, F Choppin, J Briand, JP Guillet, JG
Citation: G. Guichard et al., Melanoma peptide MART-1(27-35) analogues with enhanced binding capacity tothe human class I histocompatibility molecule HLA-A2 by introduction of a beta-amino acid residue: Implications for recognition by tumor-infiltratinglymphocytes, J MED CHEM, 43(20), 2000, pp. 3803-3808

Authors: Villada, IB Beneton, N Bony, C Connan, F Monsonego, J Bianchi, A Saiag, P Levy, JP Guillet, JG Choppin, J
Citation: Ib. Villada et al., Identification in humans of HPV-16 E6 and E7 protein epitopes recognized by cytolytic T lymphocytes in association with HLA-B18 and determination of the HLA-B18-specific binding motif, EUR J IMMUN, 30(8), 2000, pp. 2281-2289

Authors: Andrieu, M Loing, E Desoutter, JF Connan, F Choppin, J Gras-Masse, H Hanau, D Dautry-Varsat, A Guillet, JG Hosmalin, A
Citation: M. Andrieu et al., Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation, EUR J IMMUN, 30(11), 2000, pp. 3256-3265

Authors: Le Gal, FA Riteau, B Sedlik, C Khalil-Daher, I Menier, C Dausset, J Guillet, JG Carosella, ED Rouas-Freiss, N
Citation: Fa. Le Gal et al., HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes, INT IMMUNOL, 11(8), 1999, pp. 1351-1356

Authors: Pretet, JL Brussel, A Guillet, JG Butor, C
Citation: Jl. Pretet et al., Two alleles for rhesus macaque GPR15 (BOB), AIDS RES H, 15(10), 1999, pp. 945-947

Authors: Dubois-LaForgue, D Carel, JC Bourgneres, PF Guillet, JG Boitard, C
Citation: D. Dubois-laforgue et al., T-Cell response to proinsulin and insulin in type 1 and pretype 1 diabetes, J CLIN IMM, 19(2), 1999, pp. 127-134

Authors: Martinon, F Michelet, C Peguillet, I Taoufik, Y Lefebvre, P Goujard, C Guillet, JG Delfraissy, JF Lantz, O
Citation: F. Martinon et al., Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy, AIDS, 13(2), 1999, pp. 185-194

Authors: Andre, C Couton, D Gaston, J Erraji, L Renia, L Varlet, P Briand, P Guillet, JG
Citation: C. Andre et al., beta(2)-adrenergic receptor-selective agonist clenbuterol prevents Fas-induced liver apoptosis and death in mice, AM J P-GAST, 39(3), 1999, pp. G647-G654

Authors: Levy, Y Capitant, C Houhou, S Carriere, I Viard, JP Goujard, C Gastaut, JA Oksenhendler, E Boumsell, L Gomard, E Rabian, C Weiss, L Guillet, JG Delfraissy, JF Aboulker, JP Seligmann, M
Citation: Y. Levy et al., Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial, LANCET, 353(9168), 1999, pp. 1923-1929
Risultati: 1-25 | 26-33